Your ABM plan for Johnson & Johnson
Built in HubSpot for Bluecrux · 17 November 2026
01What HubSpot found
Johnson & Johnson
Johnson & Johnson is a global healthcare company focused on Innovative Medicine and MedTech, including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery and vision. [company site] [cite-38232cab-2cf8-3041-bcbd-aa32630b1f09]
It agreed on 16 November 2026 to acquire Ollin Biosciences for $2.2bn upfront, adding a late-stage ophthalmology asset. [press] [cite-7a4d9db9-6064-357f-aade-4d1f7353dcac]
It announced a more than $1bn investment in a next-generation cell therapy manufacturing facility in Pennsylvania. [press] [cite-3b035aa9-4bc9-3936-9018-d14147675212]
Its Vision business appointed Jacqueline Henderson as Company Group Chair in September 2026. [press] [cite-ef23d00f-9db6-361e-897a-6165cf580a09]
Bluecrux
Bluecrux sells value chain consulting and technology, including supply chain strategy, planning, operations, platforms, data, integrations and AI. [company site] [cite-d93a421d-56c7-3be9-b7b0-7857fd3194f1] [cite-c40a3b71-a7c6-3802-b924-39ebfb805bdd]
It serves pharma, biotech, MedTech, CPG and industrial manufacturing teams. [industries page] [cite-b84d9be7-c72f-3dda-87a8-57af5aa4497f]
Bluecrux publicly names Johnson & Johnson clients in quality and global supply planning, so the target relationship is already evidenced. [company site] [cite-d93a421d-56c7-3be9-b7b0-7857fd3194f1]
Why now
Act this week because Johnson & Johnson announced the proposed $2.2bn Ollin Biosciences acquisition on 16 November 2026, adding a late-stage ophthalmology asset. [press] [cite-7a4d9db9-6064-357f-aade-4d1f7353dcac]
With a competitor circling, Bluecrux should use this event and its existing public Johnson & Johnson supply planning and quality references to secure a new internal sponsor before the competitor does. [company site] [cite-d93a421d-56c7-3be9-b7b0-7857fd3194f1]
02Fit, unsoftened
- Account Map
- 4 offices found for Johnson & Johnson and modelled as related companies. Worth adding any missing ones by hand. [company locations] [cite-7c530e8b-f63d-3c7f-bcde-937b0e1b6b9b]
- Buying-group coverage
- 25% of the buying group named. Economic Buyer: not yet mapped Champion: not yet mapped Technical Evaluator: not yet mapped Procurement Calculated live from the roles you named. The roles themselves are self-reported.
- Segment fit
- Strong fit. Johnson & Johnson is an enterprise healthcare company, and Bluecrux says it serves pharma and MedTech organisations. [company site] [cite-38232cab-2cf8-3041-bcbd-aa32630b1f09] [industries page] [cite-b84d9be7-c72f-3dda-87a8-57af5aa4497f]
- Edge fit
- Service is likely to matter. Johnson & Johnson has multiple medicine and MedTech areas, new manufacturing investment and a new ophthalmology acquisition; Bluecrux sells transformation delivery, change and adoption services for complex value chains. [press] [cite-7a4d9db9-6064-357f-aade-4d1f7353dcac] [cite-3b035aa9-4bc9-3936-9018-d14147675212] [consulting page] [cite-c9f6abe4-a529-3d9f-be94-7bebecd27411]
03The plan
- Map the missing buying roles: use Target Accounts and Buying Roles to add a supply chain or quality champion, a technical evaluator and an economic buyer around the Ollin and Pennsylvania changes. When: Week 1
- Use the existing relationship: use Lists and Sequences to group the known Procurement contact with Bluecrux’s public Johnson & Johnson references, then ask for an internal introduction. When: Weeks 2-4
- Track the account expansion: use Workflows, Ads Audiences and ABM Reporting to monitor engagement from Johnson & Johnson’s regional entities and report movement beyond Procurement. When: Month 2
Already armed on the deal: the native Competitor field and a battlecard workflow, armed on this record, because you said “A competitor's circling”.
Your next action: This week, send Procurement a short note on the Ollin acquisition and Pennsylvania facility, using Bluecrux’s existing Johnson & Johnson supply planning and quality references, and ask for a meeting with the relevant supply chain or quality owner plus the economic buyer. [press] [cite-7a4d9db9-6064-357f-aade-4d1f7353dcac] [cite-3b035aa9-4bc9-3936-9018-d14147675212] [company site] [cite-d93a421d-56c7-3be9-b7b0-7857fd3194f1]
How HubSpot got here
- Shown liveJohnson & Johnson added to the CRM
- Shown livePlaced in the Must-Win pipeline: Important — a priority account
- Shown liveBuying-group coverage calculated: 25%
- Shown liveArmed: the native Competitor field and a battlecard workflow, armed on this record
- BackgroundBoth companies enriched by Breeze Intelligence and researched by a custom Breeze agent
- BackgroundFit analysis and Account Map built from that research
- Not shown on screenThis plan attached to the deal record